Macquarie Group LTD Abiomed Inc Transaction History

Macquarie Group LTD

$90.3 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$242.49 - $301.46 $4.02 Million - $4.99 Million	16,568 Added 3.39%	504,989 $124 Million
Q2 2022 Aug 15, 2022	SELL	$224.73 - $338.64 $1.32 Million - $1.98 Million	-5,855 Reduced 1.18%	488,421 $121 Million
Q1 2022 May 16, 2022	BUY	$277.25 - $366.29 $770,477 - $1.02 Million	2,779 Added 0.57%	494,276 $164 Million
Q4 2021 Feb 11, 2022	BUY	$300.63 - $371.35 $1.55 Million - $1.92 Million	5,162 Added 1.06%	491,497 $177 Million
Q3 2021 Nov 12, 2021	BUY	$310.19 - $376.2 $978,649 - $1.19 Million	3,155 Added 0.65%	486,335 $158 Million
Q2 2021 Aug 13, 2021	BUY	$262.71 - $351.17 $124 Million - $166 Million	472,508 Added 4427.55%	483,180 $151 Million
Q1 2021 May 14, 2021	SELL	$285.92 - $355.13 $11 Million - $13.7 Million	-38,571 Reduced 78.33%	10,672 $3.4 Million
Q4 2020 Feb 16, 2021	SELL	$251.88 - $324.2 $2.93 Million - $3.77 Million	-11,630 Reduced 19.11%	49,243 $16 Million
Q3 2020 Nov 13, 2020	SELL	$255.22 - $317.0 $2.23 Million - $2.77 Million	-8,751 Reduced 12.57%	60,873 $16.9 Million
Q2 2020 Aug 11, 2020	BUY	$141.4 - $257.09 $2.44 Million - $4.44 Million	17,266 Added 32.98%	69,624 $16.8 Million
Q1 2020 May 15, 2020	SELL	$130.51 - $196.01 $1.42 Million - $2.13 Million	-10,851 Reduced 17.17%	52,358 $7.6 Million
Q4 2019 Feb 14, 2020	BUY	$159.31 - $223.54 $3.69 Million - $5.18 Million	23,164 Added 57.84%	63,209 $10.8 Million
Q3 2019 Nov 14, 2019	SELL	$175.89 - $279.23 $16.2 Million - $25.7 Million	-92,057 Reduced 69.69%	40,045 $7.12 Million
Q2 2019 Aug 14, 2019	SELL	$250.96 - $284.94 $5.67 Million - $6.44 Million	-22,595 Reduced 14.61%	132,102 $34.4 Million
Q1 2019 May 15, 2019	BUY	$276.39 - $362.25 $31 Million - $40.6 Million	112,122 Added 263.35%	154,697 $44.2 Million
Q4 2018 Feb 15, 2019	SELL	$281.08 - $444.25 $4.08 Million - $6.45 Million	-14,522 Reduced 25.43%	42,575 $13.8 Million
Q3 2018 Nov 15, 2018	SELL	$354.53 - $449.75 $1.59 Million - $2.01 Million	-4,476 Reduced 7.27%	57,097 $25.7 Million
Q2 2018 Aug 14, 2018	SELL	$278.07 - $446.21 $20.1 Million - $32.2 Million	-72,273 Reduced 54.0%	61,573 $25.2 Million
Q1 2018 May 11, 2018	SELL	$192.49 - $295.85 $21.2 Million - $32.5 Million	-110,021 Reduced 45.12%	133,846 $38.9 Million
Q4 2017 Feb 15, 2018	SELL	$168.78 - $199.74 $3.9 Million - $4.61 Million	-23,083 Reduced 8.65%	243,867 $45.7 Million
Q3 2017 Nov 08, 2017	BUY	$145.39 - $168.6 $38.8 Million - $45 Million	266,950	266,950 $45 Million

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account